Meet Belgian and Flemish companies at BIO 2016, San Francisco

BELGIUM@BIO,SAN FRANCISCO, USA

BELGIAN PAVILION, BOOTH 419

JUNE 6-9, 2016

BELGIUM@BIO USAJUNE 6-9, 20162

INTRODUCTION 3

BELGIAN COMPANIES AT BIO 2016 SAN FRANCISCO 4

ORGANIZERS BELGIAN DELEGATION AT BIO 2016 43

PARTNERS BELGIAN DELEGATION AT BIO 2016 47

TRADE & INVESTMENT OFFICES 50

\ TABLE OF CONTENTS

BELGIUM@BIO USAJUNE 6-9, 2016 3

\ INTRODUCTION

Innovation is at the core of the life sciences sector and Belgium has a track record of developing ingenious ways to improve the quality of life of millions of people worldwide.

Not only extensive life sciences facilities support this high-level technology industry but also financial benefits for R&D companies, international collaborations that guarantee regular cash flow, world known educational systems, a promising product pipeline, and Belgium’s unique central location in Europe.

Belgium concentrates on a small territory (30,528 km2) more than 300 life sciences companies with biotech activities. In total, the life sciences sector employs more than 30,000 people (low bound estimation that does not take into account indirect employment generated by the sector). The majority of the companies is related to healthcare, but Belgium also has a strong representation of agricultural and industrial biotech companies.

The growing life sciences sector gathers 8 main Belgian universities, 19 research parks and 23 incubators, research institutes, academic hospitals, and clinical research organizations. Biotech companies have access to more than 500,000 square feet of highly flexible infrastructure.

Additional assets of Belgium include: a supportive regulatory and political environment, a highly qualified and productive workforce, a competitive tax environment especially for research companies, a prominent location and an excellent logistical and business infrastructure.


page

4CLINICS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7ABBVIE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7ADAGIO COMPANY . . . . . . . . . . . . . . . . . . . . . . . . . 8ALTIUS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8AMATSIQBIOLOGICALS . . . . . . . . . . . . . . . . . . . . . . 9AMATSISEPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9AMPLYCELL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10APITOPE INTERNATIONAL. . . . . . . . . . . . . . . . . . . 10ARGENX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11ASCLEPIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11ATOMS & ART . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12B & C GROUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12BETA-CELL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13BIOCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13BIOPARK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14BIOTECHSUBSIDY . . . . . . . . . . . . . . . . . . . . . . . . . . 14BIOTURNKEY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15BIRD & BIRD LLP . . . . . . . . . . . . . . . . . . . . . . . . . . 15BONE THERAPEUTICS . . . . . . . . . . . . . . . . . . . . . . 16BRANTSANDPATENTS . . . . . . . . . . . . . . . . . . . . . . 16CELYAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17CENTRE FOR DRUG DESIGN AND DISCOVERY . 17CER GROUPE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18CIDE-SOCRAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18CITY OF GHENT . . . . . . . . . . . . . . . . . . . . . . . . . . . 19CMAST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19CURAVAC EUROPE. . . . . . . . . . . . . . . . . . . . . . . . .20DE CLERCQ & PARTNERS . . . . . . . . . . . . . . . . . . .20DELPHI GENETICS . . . . . . . . . . . . . . . . . . . . . . . . . 21ESPERITY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21ETHERNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22EUROGENTEC . . . . . . . . . . . . . . . . . . . . . . . . . . . .22FLUIDDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23GALAPAGOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23GHENT UNIVERSITY TECH TRANSFER . . . . . . . . 24GREEN2CHEM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

page

GSK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25IMCYSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25INTERNATIONAL BIO CONSULT . . . . . . . . . . . . . . 26IT4IP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26JANSSEN PHARMACEUTICA . . . . . . . . . . . . . . . . . 27JUNEAU CAYENNE . . . . . . . . . . . . . . . . . . . . . . . . . 27KIOMED PHARMA . . . . . . . . . . . . . . . . . . . . . . . . .28KU LEUVEN RESEARCH & DEVELOPMENT . . . . .28LIEU TTOS NETWORK . . . . . . . . . . . . . . . . . . . . . . 29LRM/BIOVILLE . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29MASTHERCELL . . . . . . . . . . . . . . . . . . . . . . . . . . . .30MYCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30NAUTADUTILH . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31NLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31NOVADIP BIOSCIENCES . . . . . . . . . . . . . . . . . . . . .32NOVOSANIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32ONCODNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33ONTOFORCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33OSBORNE CLARKE . . . . . . . . . . . . . . . . . . . . . . . . 34OUAT! . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34OWIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35PFIZER. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35PHARA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36PRODIGEST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36ROUSSELOT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37TARGETOME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37TIE BRUSSELS. . . . . . . . . . . . . . . . . . . . . . . . . . . . .38TOXIKON EUROPE . . . . . . . . . . . . . . . . . . . . . . . . . 38TRINEAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39TURNSTONE COMMUNICATIONS/BIOVOX . . . . . 39UCB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40UNIVERSITÉ LIBRE DE BRUXELLES (ULB) . . . . . .40UNIVERCELLS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41UNIVERSITÉ CATHOLIQUE DE LOUVAIN (UCL) . 41VIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42WALLONIE-BRUXELLES INTERNATIONAL . . . . . . 42

\ BELGIAN COMPANIES AT BIO 2016, SAN FRANCISCO


\ WHAT ARE YOU LOOKING FOR ?

BIOTECHNOLOGY - THERAPEUTICS

ABBVIE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7APITOPE INTERNATIONAL . . . . . . . . . . . . . . . . . . 10ARGENX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11BETA-CELL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13BONE THERAPEUTICS . . . . . . . . . . . . . . . . . . . . . . 16CELYAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17CURAVAC EUROPE . . . . . . . . . . . . . . . . . . . . . . . .20ETHERNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22

EUROGENTEC . . . . . . . . . . . . . . . . . . . . . . . . . . . .22GALAPAGOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23IMCYSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25MASTHERCELL . . . . . . . . . . . . . . . . . . . . . . . . . . . .30NOVADIP BIOSCIENCES . . . . . . . . . . . . . . . . . . . . .32ONCODNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33TARGETOME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37UNIVERCELLS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

R&D SERVICES

4CLINICS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7AMATSIQBIOLOGICALS . . . . . . . . . . . . . . . . . . . . . . 9AMATSISEPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9ASCLEPIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11CER GROUPE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18

DELPHI GENETICS . . . . . . . . . . . . . . . . . . . . . . . . . 21IT4IP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26PRODIGEST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36TOXIKON EUROPE . . . . . . . . . . . . . . . . . . . . . . . . . 38

BIOTECHNOLOGY - OTHER

AMPLYCELL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10BIOPARK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

GREEN2CHEM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24ROUSSELOT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

MEDICAL TECHNOLOGY

BIOCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13BIOTURNKEY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15ESPERITY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

FLUIDDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23NOVOSANIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32

PHARMA

GSK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25JANSSEN PHARMACEUTICA . . . . . . . . . . . . . . . . . 27KIOMED PHARMA . . . . . . . . . . . . . . . . . . . . . . . . .28

PFIZER. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35UCB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40

INVESTOR

LRM / BIOVILLE . . . . . . . . . . . . . . . . . . . . . . . . . . . 29


\ WHAT ARE YOU LOOKING FOR ?

SUPPLIER & TECHNOLOGY

MYCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30ONTOFORCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33

TRINEAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

PROFESSIONAL SERVICES & CONSULTING

ADAGIO COMPANY . . . . . . . . . . . . . . . . . . . . . . . . . 8ALTIUS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8ATOMS & ART . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12B & C GROUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12BIOTECHSUBSIDY . . . . . . . . . . . . . . . . . . . . . . . . . . 14BIRD & BIRD LLP . . . . . . . . . . . . . . . . . . . . . . . . . . 15BRANTSANDPATENTS . . . . . . . . . . . . . . . . . . . . . . 16CIDE-SOCRAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18CMAST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

DE CLERCQ & PARTNERS . . . . . . . . . . . . . . . . . . .20INTERNATIONAL BIO CONSULT . . . . . . . . . . . . . . 26JUNEAU CAYENNE . . . . . . . . . . . . . . . . . . . . . . . . . 27NAUTADUTILH . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31NLO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31OSBORNE CLARKE . . . . . . . . . . . . . . . . . . . . . . . . 34OUAT! . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34PHARA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36TURNSTONE COMMUNICATIONS / BIOVOX . . . . 39

PUBLIC / NON-PROFIT ORGANISATIONS

BIO.BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48BIOWIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .44BRUSSELS INVEST & EXPORT . . . . . . . . . . . . . . .44 CENTRE FOR DRUG DESIGN AND DISCOVERY . 17CITY OF GHENT . . . . . . . . . . . . . . . . . . . . . . . . . . . 19FLANDERS INVESTMENT & TRADE . . . . . . . . . . . 45FLANDERSBIO . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45GHENT UNIVERSITY TECH TRANSFER . . . . . . . . 24KU LEUVEN RESEARCH & DEVELOPMENT . . . . .28LIEU TTOS NETWORK . . . . . . . . . . . . . . . . . . . . . . 29LIFETECH.BRUSSELS . . . . . . . . . . . . . . . . . . . . . . . 46OWIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35

PHARMA.BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48TIE BRUSSELS. . . . . . . . . . . . . . . . . . . . . . . . . . . . .38UNIVERSITÉ LIBRE DE BRUXELLES (ULB) . . . . . .40UNIVERSITÉ CATHOLIQUE DE LOUVAIN (UCL) . 41VIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42WALLONIE-BRUXELLES INTERNATIONAL . . . . . . 42WALLONIA EXPORT-INVESTMENT AGENCY (AWEX) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46WALLONIA REGION TECHNOLOGY DEPARTMENT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49


Drève Richelle 161 - Batiment C • BE-1410 WATERLOO T +32 2 609 51 20 www.4clinics.com

Delegate: Mehdi CHELBI, Director Business Development • [email protected]

Avenue Einstein 14 • BE-1300 WAVRE T +32 10 47 78 11 www.abbvie.com

Delegates: Jarek OLESZCZUK, General Manager • [email protected] Tineke VAN HOOLAND, External Affairs Director • [email protected]

4Clinics has well-known expertise in vaccine, therapeutic vaccine, immunology and cell therapies. 4Clinics expertise covers all aspects of clinical development.

Category: Biotechnology - R&D Services

AbbVie is a biopharmaceutical company that unites a biotech spirit with the strength of a successful pharmaceutical business. Innovation drives our science. Patients drive our purpose.

Category: Biotechnology - Therapeutics

\ ABBVIE

\ 4CLINICS


\ ADAGIO COMPANY

\ ALTIUS

Sint-Denijslaan 96 • BE-9000 GHENT T +32 9 279 42 48 www.adagio.company

Delegate: Lucas DECUYPERE, CEO • [email protected]

Havenlaan 86C B414 • BE-1000 BRUSSELS T +32 2 426 14 14 • www.altius.com

Delegate: Christophe RONSE, Partner • [email protected]

Digital business advisory & technology services company, driving revenue & profits for life sciences companies through the expert use of multi-channel marketing & marketing automation.

Category: Professional Services & Consulting

ALTIUS is an independent full-service Belgian law firm with a strong Life Science practice, advising clients on contentious and non-contentious mat-ters in the life science and healthcare industry.



\ AMATSISEPS

\ AMATSIQBIOLOGICALS

BioIncubator Building, Technologiepark 4 • BE-9052 GHENT T +32 9 241 11 04 • www.q-biologicals.be

Delegates: Annie VAN BROEKHOVEN, CEO • [email protected] Karine CLAUWAERT, Director Business Development • [email protected]

BioIncubator Building, Technologiepark 4 • BE-9052 GHENT T +32 9 261 69 01 www.sepspharma.com

Delegate: Jody VOORSPOELS, CSO • [email protected]

AmatsiQBiologicals is a CDMO offering a range of process development and biomanufacturing services to customers in the biopharmaceutical industry and beyond.

Category: R&D Services

AmatsiSEPS provides drug product de-velopment services and is dedicated to the development of innovative drug delivery systems serving solutions to enhance bioavailability and control drug release.



\ AMPLYCELL

\ APITOPE INTERNATIONAL

Avenue Hippocrate 5 • BE-4000 LIÈGE T +32 42 66 94 93 • www.amplycell.com

Delegates: Geoffrey HOLSBEEK, CEO • [email protected] Julien ISOARD, Business Development • [email protected] Tanguy ROWET, Business development • [email protected]

Agoralaan A-bis • BE-3590 DIEPENBEEK T +44 79 19 14 49 01 www.apitope.com

Delegate: Hayley FRENCH, Commercial Director & General Counsel • [email protected]

Amplycell has developed stimulation technologies that activates cell lines metabolism in order to get higher yield of monoclonal antibody and recombinant protein productions up to 10 times.

Category: Biotechnology - Other

Development of highly selective immu-no-therapies for autoimmune diseases. Interested in outlicensing programmes and also in discovery alliances for suto-immune antigen targets of interest.



\ ASCLEPIA

\ ARGENX

Industriepark Zwijnaarde 7, Building C • BE-9052 GHENT T +32 9 310 34 00 www.argenx.com

Delegate: Debbie ALLEN, Senior VP Business Development • [email protected]

Damvalleistraat 49 • BE-9070 DESTELBERGEN T +32 468 13 70 14 www.asclepia.com

Delegate: Frederik DEROOSE, CEO • [email protected]

argenx combines the diversity of the llama immune system with antibody engineering to advance a clinical product pipeline serving patients with cancer and severe autoimmune diseases.


Asclepia offers medicinal chemistry oriented research and services by de-signing and delivering innovative, therapeutically relevant, drug-like com-pounds, from early stage discovery till IND package.



\ ATOMS & ART

\ B & C GROUP

Grote markt 12 bus 3 • BE-3200 AARSCHOT T +32 494 57 81 22 • www.atomsandart.com

Delegates: Robert DEKKER, Founding Partner • [email protected] Leen LIMBOURG, Founding Partner • [email protected]

Watson & Crick Hill Rue Granbonpré 11 • BE-1435 MONT-SAINT-GUIBERT T +32 10 23 74 44 • www.bnc-group.com

Delegates: Philippe VAN DER HOFSTADT, CEO • [email protected] David FONTAINE, Chief Business Development Officer • [email protected] Michael DUDA, Vice President US Operations • [email protected]

We support companies and investors by providing integrated development consulting, operational due diligence and project management to addresses unmet medical needs in a viable business context.


B&C Group supports clinical research with high-quality and efficient packag-ing, distribution and archiving services for drugs & related supplies as well as for biomedical samples on a worldwide basis.



\ BIOCARTIS

\ BETA-CELL

Researchpark Z.1 - 310 • BE-1731 ZELLIK T +32 2 477 43 49 www.beta-cell.com

Delegate: Kris MOTMANS, Corporate Development • [email protected]

Generaal De Wittelaan 11 B3 • BE-2800 MECHELEN T +32 15 63 26 00 www.biocartis.com

Delegate: Erik VOSSENAAR, Business Development Director • [email protected]

Beta-Cell nv is a biopharmaceutical company that focusses on the development of cell-based products for the treatment of diabetes.


Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics (MDx) company delivering MDx solutions that address key unmet clinical needs in oncology and infectious diseases.

Category: Medical Technology


\ BIOPARK

\ BIOTECHSUBSIDY

Rue Adrienne Bolland 8b2 • BE-6041 GOSSELIES T +32 2 650 98 69 www.biopark.be

Delegate: Dominique DEMONTE, Director • [email protected]

Sparhoekdreef 57 • BE-9880 AALTER T +32 9 324 69 20 www.biotechsubsidy.com

Delegate: Marc VAN DE CRAEN, Managing Director • [email protected]

With 3 academic institutes, 32 compa-nies, an incubator and a training cen-tre, the Biopark ULB Charleroi has de-veloped a smart specialization strategy in IMMUNOLOGY, CELL THERAPY and IMAGING.


We design a long-term strategy and planning for your biotech projects. If required we will also secure funding to execute your projects.



\ BIOTURNKEY

\ BIRD & BIRD LLP

Rue de la Science 8 • BE-6900 AYE T +32 486 13 58 57 • www.bioturnkey.com

Delegates: Frederic TONGLET, CEO • [email protected] François LESAGE, CBO • [email protected] Mary Patricia MOYER, CSO • [email protected]

Avenue Louise - Louizalaan 235 bte 1 • BE-1050 BRUSSELS T +32 2 282 60 00 • www.twobirds.com

Delegates: Marc MARTENS, Partner • [email protected] Anne-Charlotte LE BIHAN, Partner • [email protected]

cGMP and Clinical readiness through disruptive closed system devices powered by 20+ year manufacturing expertise. US/UE BIOTURNKEY offers total quality anytime anywhere at a fraction of the costs.


With over 1,100 lawyers and legal prac-titioners across a worldwide network of 28 offices, Bird & Bird specialises in delivering expertise in several sectors including life sciences.



\ BRANTSANDPATENTS

Rue Auguste Piccard 37 • BE-6041 GOSSELIES T +32 2 529 59 90 • www.bonetherapeutics.com/en

Delegates: Thomas LIÉNARD, Chief Business Officer • [email protected] Enrico BASTIANELLI, Chief Executive Officer • [email protected]

Pauline Van Pottelsberghelaan 24 • BE-9051 GHENT T +32 9 230 83 38 • www.brantsandpatents.com

Delegates: Johan BRANTS, Belgian, Dutch and European Patent Attorney • [email protected] Ellen CRABBE, European Patent Attorney • [email protected]

Bone Therapeutics is a biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention.


We are a consultancy firm specialized in patent, trademark and design proce-dures and assist our clients in develop-ing, protecting, exploiting and enforc-ing their innovations and trademarks.


\ BONE THERAPEUTICS


\ CELYAD

\ CENTRE FOR DRUG DESIGN AND DISCOVERY

Rue Edouard Belin 12 • BE-1345 MONT-SAINT-GUIBERT T +32 10 39 41 00 www.celyad.com

Delegates: Georges RAWADI, VP Business Development • [email protected] Christian HOMSY, CEO • [email protected]

Gaston Geenslaan 1 • BE-3001 LEUVEN T +32 16 85 26 05 • www.cd3.eu

Delegates: Patrick CHALTIN, Managing Director • [email protected] Stefaan ALLEMEERSCH, Director Business Development • [email protected]

Celyad is a leader in cell therapy en-gineering with development programs in cardiovascular disease (Phase III) and immuno-oncology (Phase I/IIa). Clinical data expected in both indications by mid-2016.


The Centre for Drug Design and Discovery (CD3) focuses on the discovery of new and innovative small molecule drugs in collaboration with academic research groups or small (spin-off) companies.

Category: Public/Non-Profit Organisations


\ CIDE-SOCRAN

Novalis Science Park, Rue de la Science 8 • BE-6900 AYE T +32 84 22 02 11 • www.cergroupe.be

Delegates: Bertrand MOINET, CEO • [email protected] François CÔTE, Project Manager & Business Developer • [email protected]

Rue Lambert Lombard 3 • BE-4000 LIÈGE T +32 4 220 56 00 • www.cide-socran.be

Delegate: Bertrand JOIRET, Export Manager/Project Manager • [email protected]

CER Groupe is a Belgian Research Center providing services, products and R&D in veterinarian, food safety, biotech and biomedical areas through preclinical, bioproduction and diagnostic activities.


With 20 in-house technical and business consultants, Cide-Socran is specialized in the support of biotech companies in commercial and financial fields (market surveys, financial plans, fundraising,..).


\ CER GROUPE


\ CMAST

\ CITY OF GHENT

Botermarkt 1 • BE-9000 GHENT T +32 497 45 26 75 • www.investinghent.be

Delegate: Els DE LEEUW, Managing Director Economic Services • [email protected]

Georges Van Dammeplein 57 • BE-9140 TEMSE T +32 498 10 65 35 • c-mast.com

Delegates: Glenn VAN DAEL, Managing Director • [email protected] Karin VAN DEN EEDEN, Contract & Business Relations Manager • [email protected]

By attracting new R&D-intensive com-panies the city of Ghent wants to further strengthen the position of the city and the whole region of Flanders as one of Europe’s major life sciences hotspots.


CMAST is a specialized consultancy and project management service provider in the domain of R&D, Innovation and Supply Chain within the Life Sciences industry.



\ DE CLERCQ & PARTNERS

Avenue de Villefranche 80 • BE-1330 RIXENSART T +32 2 686 04 40 www.curavac.com

Delegates: Stephane HUBERTY, CEO • [email protected] Nicolas HAVELANGE, COO • [email protected]

CuraVac is a clinical stage biotech company that develops therapeu-tic vaccines for autoimmune diseas-es. CuraVac’s first targeted immuno-therapy is currently being tested on myasthenia gravis.


\ CURAVAC EUROPE

Edgard Gevaertdreef 10a • BE-9830 SINT-MARTENS-LATEM T +32 9 280 23 40 • www.dcp-ip.com

Delegates: Ann DE CLERCQ, European & Belgian Patent Attorney, Founding Partner • [email protected] Andrej MICHALÍK, European Patent Attorney • [email protected]

De Clercq & Partners is a team of highly qualified European and Belgian patent attorneys, patent advisers, Benelux and European trademark attorneys and legal representatives.



\ DELPHI GENETICS

\ ESPERITY

Rue Antoine de Saint-Exupery 5 • BE-6041 CHARLEROI T +32 71 25 10 00 • www.delphigenetics.com

Delegates: Thierry VAN REETH, Scientific & Sales Manager • [email protected] Marc DECHAMPS, Chief Operating Officer • [email protected]

Veldkapelgaarde 30b1.30.30 • BE-1200 BRUSSELS T +32 476 24 10 86 www.esperity.com

Delegate: Mitchell SILVA, CEO • [email protected]

Delphi Genetics is providing technology and flexibility in bioproduction of plasmid DNA and recombinant proteins (including antibodies) based on robust and antibiotic free processes.


Esperity is a patient platform that gives its users free access to information on the latest medical treatments. We speed up patient recruitment for clinical trials and increase trial retention.



\ EUROGENTEC

\ ETHERNA

Arthur De Coninckstraat 11 • BE-3070 LEUVEN T +32 475 96 52 57 • www.etherna.be

Delegates: Dirk REYN, CEO • [email protected] Dirk VAN BROEKHOVEN, COO • [email protected]

eTheRNA’ s mission is to help patients to overcome certain cancers and infec-tious diseases by developing immuno-therapies that target the fundamental role of dendritic cells in the human im-munesystem.


Rue Bois Saint-Jean 5 • BE-4102 SERAING T +32 4 372 74 00 • www.eurogentec.com

Delegates: Pascal BOLON, Biologics Sales & Marketing Manager • [email protected] Jean-Michel SCHAUS, Biologics Account Manager • [email protected]

Eurogentec is an FDA inspected CMO (2011, 2013, 2014), that offers GMP offers GMP contract manufacturing of proteins, conjugates, and plasmids for clinical and commercial supply.



\ FLUIDDA

\ GALAPAGOS

Groeningenlei 132 • BE-2550 KONTICH T +32 3 450 87 21 www.fluidda.com

Delegate: Lieven NUYTTENS, CEO US Division • [email protected]

Generaal De Wittelaan L11 A3 • BE-2800 MECHELEN T +32 15 34 29 00 • www.glpg.com

Delegates: Andre HOEKEMA, SVP Corporate Development • [email protected] Paul VAN DER HORST, Director Business Development & European Investor Relations • [email protected]

FLUIDDA is the world leader in the field of Functional Respiratory Imaging (FRI) research and development.


Galapagos is focused on the develop-ment and commercialization of novel medicines that will improve people’s lives.



\ GREEN2CHEM

\ GHENT UNIVERSITY TECH TRANSFER

iGent Tower - Technologiepark 15 • BE-9052 GHENT T +32 9 264 78 83 • www.ugent.be/techtransfer/en

Delegates: Philippe JACOBS, European Patent Attorney • [email protected] Piet DE VOS, Licensing Manager • [email protected]

As the Tech Transfer Office of Ghent University, we provide support with licensing, IP transfer and collaboration projects as well as patent prosecution.


Rue des Foudriers 1 • BE-7822 GHISLENGHIEN T +32 499 56 71 46 www.green2Chem.com

Delegate: Paul-Evence COPPÉE, CEO/CFO • [email protected]

Green2Chem was founded in 2011 with the vision to develop the best Root Bio-Reactors in the market, for a wide range of applications including drugs such as recombinant proteins and diagnostics.



\ GSK

\ IMCYSE

Rue de l’Institut 89 • BE-1330 RIXENSART T +32 2 656 81 11 www.gsk.com

Delegate: Philippe DENOEL, Head of External R&D • [email protected]

Avenue de l’hôpital 1 • BE-4000 LIÈGE T +32 4 366 47 37 www.imcyse.com

Delegate: Pierre VANDEPAPELIÈRE, CEO • [email protected]

GSK is a world’s leading vaccine compa-ny, with around 40 vaccines for infants, adolescents and adults and 16 vaccine candidates in clinical development in our 3 R&D centres in Italy, Belgium and USA.

Category: Pharma

Imcyse develops a technology platform of novel & active immunotherapies that have the potential to cure autoimmune and inflammatory severe diseases such as multiple sclerosis, type 1 diabetes.


IBC


\ INTERNATIONAL BIO CONSULT

\ IT4IP

Avenue Louise 193 • BE-1000 BRUSSELS T +32 473 58 26 38 • www.internationalbioconsult.com

Delegates: Ilham SABOUR, General Manager • [email protected] Julien Alexandre PERROTTA, International Business Development • [email protected]

Design and management of agricultural ecosystems and smart villages according to the principles of the urban and rural permaculture (soils rehabilitation, pas-toral intelligence, water catchment...).


Avenue Jean-Etienne Lenoir 1 • BE-1348 LOUVAIN-LA-NEUVE T +32 10 22 61 14 • www.it4ip.be

Delegates: Etienne FERAIN, CEO • [email protected] Hugues LAMBERT, Business Development Assistant • [email protected] Rodais CHANSON, Business Developer • [email protected] Juan HERRERO, Exclusive North American Representative of it4ip Track-Etched Membranes • [email protected]

Leader in the manufacturing of track-etched filter membranes (TEMs). We of-fer: Standard filter membranes, Custom-ized products, Devices & Innovation.



\ JUNEAU CAYENNE

\ JANSSEN PHARMACEUTICA

Turnhoutseweg 30 • BE-2340 BEERSE T +32 14 60 21 11 • www.janssenbelgium.be

Delegate: Frederik WITTOCK, Sr Director R&D Communications • [email protected]

Steenweg op Antwerpen 99 bus 2 • BE-2300 TURNHOUT T +32 14 80 04 40 www.juneaucayenne.com

Delegate: Nicole VERBEECK, CEO • [email protected]

Janssen Pharmaceutica NV is a global center for integrated R&D, production and distribution of medicines. The company has several sites in Belgium, employs about 4500 people and is active in a wide range of therapeutic areas including neurosciences, oncology and infectious diseases.

Juneau Cayenne is a global healthcare communication agency. We aim for best-in-class branding, communication and design services to clients across pharma, biotech, and healthcare.



\ KU LEUVEN RESEARCH & DEVELOPMENT

\ KIOMED PHARMA

Rue Haute Claire 4 • BE-4040 HERSTAL T +32 4 228 80 40 • www.kiomedpharma.com

Delegates: Houtai CHOUMANE, CEO • [email protected] Sandrine GAUTIER, Value Stream Manager • [email protected]

KiOmed Pharma designs and develops innovative osteoarthritis treatments and aesthetic medical devices based on proprietary animal-free chitosan biomaterials.

Category: Pharma

Waaistraat 6 • BE-3000 LEUVEN T +32 16 85 26 05 www.kuleuven.be/lrd

Delegate: Patrick CHALTIN, Managing Director CD3 • [email protected]

KU Leuven Research & Development (LRD) is the TTO of the University of Leuven (KU Leuven) and is dedicated to transferring knowledge and technolo-gies of KU Leuven to the marketplace.



\ LRM/BIOVILLE

\ LIEU TTOS NETWORK

Place de l’Université 1 bte L0.01.05 • BE-1348 LOUVAIN-LA-NEUVE T +32 10 47 25 42 • www.reseaulieu.be

Delegates: Marlène DUBUISSON, Technological Advisor Biotech & Health • [email protected] & Patrick DI STEFANO, Industrial Relations Manager • [email protected]

Kempische Steenweg 311 bus 4.01 • BE-3500 HASSELT T +32 11 24 68 01 www.lrm.be

Delegate: Barbara LEYMAN, Head of Health & Care • [email protected]

LIEU is the network of TTOs of the Belgian French-speaking universities and higher education institutions. LIEU connects re-search and business through collabora-tions, IP management and tech transfer.


LRM, Health & Care investment fund managing BioVille, an all-in-one Health & Care incubator/accelerator: flexible offices and state-of-the-art laborato-ries, admin & tech services.

Category: Investor


\ MASTHERCELL

\ MYCARTIS

Rue Auguste Piccard 48 • BE-6041 GOSSELIES T +32 71 34 76 29 • www.masthercell.com

Delegates: Romain DE RAUVILLE, Business Engineer • [email protected] Hugues BULTOT, CEO • [email protected]

MaSTherCell is a dynamic and glo-bal Contract Development and Manu-facturing Organisation (CDMO) on a mission to deliver optimized process industrialisation capacities to cell therapy organisations.


Technologiepark 4 • BE-9052 GHENT T +32 9 241 11 40 www.mycartis.net

Delegates: Francois TOPIN, SVP Strategic Planning • [email protected] Joris SCHUURMANS, CEO • [email protected]

MyCartis is devoted to improve health-care for everyone. Our next generation multiplexed technology EvalutionTM delivers an in-depth analysis of a wide range of biomarkers quickly, accurately and cost.

Category: Supplier & Technology


\ NLO

\ NAUTADUTILH

Chaussée de la Hulpe 120 • BE-1000 BRUSSELS T +32 2 566 88 00 • www.nautadutilh.com

Delegates: Jo VANWITTENBERGH, Marketing & BD Responsible • [email protected] Christel BRION, Senior Associate • [email protected]

Technologiepark 19 • BE-9052 GHENT T +32 9 24 09 888 • www.nlo.eu

Delegates: Caroline PALLARD, Dutch and European Patent Attorney • [email protected] & Emil POT, European Patent Attorney • [email protected] & Peter TEN HAAFT, Dutch and European Patent Attorney • [email protected]

NautaDutilh provides legal services to biotech, pharma and medtech compa-nies. From universities and their spin-offs to mature organisations and from professional associations to investors.


We protect and fortify your innovations, models and trademarks, thanks to our extensive range of our Intellectual Prop-erty services and the expertise of our patent, trademark and design attorneys.



\ NOVADIP BIOSCIENCES

\ NOVOSANIS

Rue Granbonpré 11 (building H) • BE-1435 MONT-SAINT-GUIBERT T +32 10 77 92 20 www.novadip.com

Delegate: Jean-François POLLET, CEO • [email protected]

Novadip Biosciences is an advanced biopharmaceutical company focused on a new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.


Bijkhoevelaan 32c • BE-2110 WIJNEGEM T +32 3 485 50 16 www.novosanis.com

Delegates: Vanessa VANKERCKHOVEN, CEO • [email protected] Koen BEYERS, CTO • [email protected]

We strive to detect, treat and prevent infectious diseases.



\ ONTOFORCE

\ ONCODNA

Av. Georges Lemaître 25 • BE-6041 GOSSELIES T +32 71 34 78 99 www.oncodna.com

Delegate: Jean-Pol DETIFFE, Founder, Chief Executive Officer • [email protected]

Ottergemsesteenweg-Zuid 808 • BE-9000 GHENT T +32 4 268 21 82 www.ontoforce.com

Delegates: Filip PATTYN, Scientific Lead • [email protected] Hans CONSTANDT, CEO • [email protected]

OncoDNA, The Cancer Theranostic Company, is the European leading on-cology company providing innovative solutions for cancer treatments.


With DISQOVER, ONTOFORCE’s user-friendly semantic search platform, you find life changing data faster, smarter and simpler. DISQOVER turns data -big and small- into smart data.



\ OUAT!

\ OSBORNE CLARKE

Avenue Marnix 23 • BE-1000 BRUSSELS T +32 2 515 93 00 osborneclarke.com

Delegate: David HAEX, Partner/Lawyer • [email protected]

We are an international law firm with 700+ talented lawyers working at 20 offices throughout Europe and the US. We regularly work for clients in the pharma, biotech and medtech sectors.


Rue d’Alost 7 • BE-1000 BRUSSELS T +32 2 880 29 68 • www.ouat.eu

Delegates: Matthieu EGLOFF, Architect Marketing, Partner • [email protected] Emilie PINARD, Architect Marketing • [email protected] Nicolas VERTOMMEN, Architect Marketing, Partner • [email protected]

With its Biotechnology and Marketing expertise, OUAT! is able to identify and understand the value of complex scientific advances to deliver simple and integrated marketing tools that sell.



\ PFIZER

\ OWIN

Boulevard Baudouin 12 • BE-1000 BRUSSELS T +32 2 421 84 67 http://openiwin.com

Delegate: Philippe LACHAPELLE, Member of the Board • [email protected]

Pleinlaan 17 • BE-1050 ELSENE T +32 2 554 66 60 www.pfizer.be

Delegate: Dirk VANDER MIJNSBRUGGE, Sr. Director Medical Affairs Lead EU Western Cluster • [email protected]

An Association of Governments, Univer-sities, and Trade Agencies dedicated to facilitate startups and technology com-mercialization.

Category: Public / Non-Profit Organisations

Developing Innovative Medicines to improve patients life.

Category: Pharma


\ PRODIGEST

\ PHARA

Anneessensstraat 3-5 B9 • BE-2018 ANTWERP T +32 3 293 90 84 • www.phara-consulting.be

Delegates: Ingrid THEEUWES, Managing Director • [email protected] & Frank VANDENDRIESSCHE, Director Scientific and Strategic Regulatory Affairs • [email protected]

PhaRA is a consultancy firm in EU Regula-tory Affairs, providing both strategic and hands-on support (CTA, PIP, Orphan Drug, Scientific Advice, CP/DCP/MRP, MAA, etc).


Technologiepark 3 • BE-9052 GHENT T +32 9 241 11 90 www.prodigest.eu

Delegate: Massimo MARZORATI, Business Development Director • [email protected]

ProDigest is a product leader in the de-velopment and use - as service provider - of unique laboratory models of the hu-man and animal gastrointestinal tract (SHIME® enabling technology platform).



\ TARGETOME

\ ROUSSELOT

Meulestedekaai 81 • BE-9000 GHENT T +32 9 255 18 60 • www.rousselot.com

Delegates: Jos OLIJVE, Senior Project Manager • [email protected] Pierre-Albert THOMAS, Global Technical Support Manager • [email protected]

Avenue Hippocrate 5 • BE-4000 LIÈGE T +32 4 266 94 95 www.targetome.be

Delegate: Christophe VAN HUFFEL, CEO • [email protected]

Rousselot is recognized as the leader in the production of high quality gelatins for food, pharmaceutical and medical applications. We offer fit for use gelatins very low in endotoxin and controlled in microbiology. Rousselot is a brand of Darling Ingredients.


TARGETOME is a biopharmaceutical company developing targeted therapies against cancer, focusing on therapies with unmet medical needs, such as pancreatic cancer, or liver metastases.



\ TOXIKON EUROPE

\ TIE BRUSSELS

Boulevard Baudouin 12 • BE-1080 BRUSSELS T +32 2 421 86 68 http://brussels.tie.org/en/

Delegate: Ines JURISIC, Executive Director • [email protected]

TiE Brussels is about fostering entre-preneurship in Belgium and Europe. We are a regional chapter of TIE, the world’s largest entrepreneur’s network with nearly 1500 events held per year.

Category: Public / Non-Profit Organisations

Romeinsestraat 12 • BE-3001 LEUVEN T +32 16 40 04 84 www.toxikon.com

Delegates: Kevin BREESCH, Program Manager • [email protected] Jos BOLLEN, Managing Director • [email protected]

Toxikon is an international preclinical & CMC lab with GMP and GLP accreditations and over 35 years of experience in supporting drug product development programs from concept to final product.



\ TURNSTONE COMMUNICATIONS/BIOVOX

\ TRINEAN

Dulle Grietlaaan 17/3 • BE-9050 GENTBRUGGE T +32 9 272 75 35 www.trinean.com

Delegate: Philippe STAS, CEO • [email protected]

Voorhavenlaan 14A • BE-9000 GHENT T +32 9 218 71 97 www.turnstone.be

Delegate: Ann VAN GYSEL, CEO • [email protected]

Trinean is a Belgium based technology provider, focusing on micro-volume mo-lecular spectroscopy for biological sam-ple quantification and quality control.


BioVox showcases life sciences break-throughs by and for Belgian innova-tors and is a service brought to you by Turnstone Communications, delivering full consultancy for healthcare profes-sionals.


discover our news platform


\ UNIVERSITÉ LIBRE DE BRUXELLES (ULB)

\ UCB

Allée de la Recherche 60 • BE-1070 BRUSSELS T +32 2 559 99 99 www.ucb.com

Delegate: Didier MALHERBE, VP Public Affairs UCB & General Manager UCB Belgium • [email protected]

UCB is a global biopharmaceutical com-pany focused on the discovery and de-velopment of innovative medicines and solutions for people living with severe diseases in neurology and immunology.

Category: Pharma

Avenue Franklin D. Roosevelt 50 • BE-1050 BRUSSELS T +32 2 650 98 69 • www.ulb.ac.be

Delegate: Dominique DEMONTE, Director of the Biopark ULB • [email protected]

The Université libre de Bruxelles is a multicultural university with a long tradition of excellence in Research (4 Scientific Nobel Prizes). Critical thinking and freedom are part of the ULB’s DNA.



\ UNIVERSITÉ CATHOLIQUE DE LOUVAIN (UCL)

\ UNIVERCELLS

Rue Auguste Piccard 48 • BE-6041 GOSSELIES T +32 71 91 98 55 • www.univercells.com

Delegates: Benjamin DAMIEN, Director of Business Development • [email protected] José CASTILLO, CTO • [email protected]

Place de l’Université 1 • BE-1348 LOUVAIN-LA-NEUVE T +32 10 47 24 71 www.ltto.com/en

Delegate: Xavier LAMPE, Scientific Advisor • [email protected]

Univercells is making biologics drugs available and affordable through tech-nology innovation, and offers a com-plete “end-to-end” package for the local production of biosimilars and vaccines.


LTTO is the UCL knowledge transfer offices. We challenge the process of maximising the research results and the technology transfer from our university towards companies in life sciences business.



\ WALLONIE-BRUXELLES INTERNATIONAL

\ VIB

Rijvisschestraat 120 • BE-9052 GHENT • T +32 9 244 66 11 • www.vib.be

Delegates: Jan DEMOLDER, European Patent Attorney • [email protected] Jérôme VAN BIERVLIET, Senior Business Development Manager • [email protected] Floor STAM, Business Development Manager • [email protected]

VIB is an entrepreneurial institute in-volved in frontline life sciences research and its translation in products and eco-nomic activities. VIB has a number of opportunities for partnering at BIO.


Place Sainctelette 2 • BE-1080 BRUSSELS T +32 1 85 73 33 89 51 www.wbi.be

Delegate: Maxime VAN CAUTER, Scientific Liaison Officer • [email protected]

WBI facilitates and funds research col-laborations between companies, re-search centers and universities.

IS A PROUD MEMBER OF THE FLANDERS WELCOME TEAM - LIFE SCIENCES


\ ORGANIZERS BELGIAN DELEGATION AT BIO 2016

BIOWIN 44

BRUSSELS INVEST & EXPORT 44

FLANDERS INVESTMENT & TRADE 45

FLANDERSBIO 45

LIFETECH.BRUSSELS 46

WALLONIA EXPORT-INVESTMENT AGENCY (AWEX) 46


Avenue Louise 500 b4 • BE-1050 BRUSSELS T +32 2 800 40 00 • www.brusselsinvestexport.be

Delegates: Marc DAUGHERTY, Area Manager North America, Export • [email protected] Eric GABRYS, Brussels Region Trade Commissioner • [email protected]

Maison de l’Industrie, Rue Auguste Piccard 20 • BE-6041 GOSSELIES T +32 474 5202 69 www.biowin.org

Delegate: Frederik DRUCK, Deputy Managing Director – Head of Communications, International Relations & Training • [email protected]

Brussels Invest & Export is the foreign trade and investment agency of the Brussels-Capital Region. It aims to promote the internationalization of the Brussels economy.

BioWin, the Health Cluster of Wallonia (Belgium) is the reference player for all the stakeholders involved in innovative R&D projects and/or skills development in the field of health biotechnology.

\ BRUSSELS INVEST & EXPORT

\ BIOWIN


Jean-Baptiste de Ghellincklaan 13 bus 0102 • BE-9051 GHENT T +32 9 241 80 41 • www.flandersbio.be

Delegates: Henk JOOS, Managing Director • [email protected] Ann DEBUNNE, Programme Manager • [email protected] Willem DHOOGE, Programme Manager • [email protected]

FlandersBio is the networking or-ganization for the life sciences sector in Flanders, with currently 300+ members. We can assist you in finding your partner within the network of life sciences actors.

Koning Albert II-laan 37 • BE-1030 BRUSSELS T +32 2 504 87 11 • www.flandersinvestmentandtrade.com

Delegates: Claire TILLEKAERTS, CEO • [email protected] & Marc VAN GASTEL, Head of Department Invest • [email protected] & Jan WAUTERS, Technology Attaché • [email protected] & Mieke PYNNAERT, Trade & Investment Commissioner in Montréal • [email protected] & Jeroen DE VUYST, Head of Department - Trade Fairs & Events • [email protected] & Jozefien WILLEMEN, Invest deputy in LA • [email protected]

Flanders Investment & Trade is the government agency supporting home-based companies doing business abroad and foreign companies looking to set up or expand operations in Flanders, the northern region of Belgium.

\ FLANDERSBIO

\ FLANDERS INVESTMENT & TRADE




\ LIFETECH.BRUSSELS

\ WALLONIA EXPORT-INVESTMENT AGENCY (AWEX)

Place Sainctelette 2 • BE-1080 BRUSSELS T +32 2 421 82 11 • www.investinwallonia.be

Delegates: Jean-Pierre MARCELLE, Chief Operating Officer • [email protected] Francis KANIA, Director Americas • [email protected] Philippe JANSSENS DE VAREBEKE, Life Sciences Expert • [email protected] Yaël HAUMONT, Area Manager North America • [email protected]

Tour & Taxis - Avenue du Port 86c b211 BE-1000 BRUSSELS T +32 2 422 00 31 www.lifetechbrussels.com

Delegate: Camille MOMMER, Business Developer • [email protected]

The Wallonia Foreign Trade and Invest-ment Agency is responsible for export promotion of Wallonia-based companies and foreign investment attraction in Wallonia, Belgium.

lifetech.brussels gathers around 150 companies, hospitals and R&D labs. By supporting startups and identifying potential synergies, the cluster drives Health, Innovation and Entrepreneurship.


\ PARTNERS BELGIAN DELEGATION AT BIO 2016

BIO.BE 48

PHARMA.BE 48

WALLONIA REGION TECHNOLOGY DEPARTMENT 49


\ PHARMA.BE

\ BIO.BE

Chaussée de la Hulpe 166 BE-1170 BRUSSELS T +32 2 661 91 11 www.pharma.be

Delegate: Catherine RUTTEN, CEO • [email protected]

Auguste Reyerslaan 80 BE-1030 BRUSSELS T +32 2 238 98 44 http://bio.be

Delegate: Cathy PLASMAN, Secretary General • [email protected]

pharma.be is the association of the innovative pharmaceutical industry in Belgium, representing the interests of 130+ SMEs, biotech start-ups and mul-tinational companies and some 34,000 employees.

bio.be is the federation of Belgian companies active in the biosciences and is part of essenscia. We represent the interests of our members regarding legislation, policy and standards at Be-EU level.


\ WALLONIA REGION TECHNOLOGY DEVELOPMENT DEPARTMENT

Place de la Wallonie 1 BE-5100 NAMUR T +32 81 33 45 62 www.recherche-technologie.wallonie.be

Delegates: Alain DE MOL, Life Science Advisor • [email protected] Vinciane GRIMARD, Life Science Advisor • [email protected]

Through its Technology Development Department, the Wallonia Region has designed a series of incentives to boost regional innovation and research and to meet the needs of all companies, from start-ups to well-established enterprises.Wallonia’s R&D incentives include:- Grants for basic industrial research (up to 80% R&D costs);

- Recoverable advances for applied research (up to 75% R&D costs);

- Other possibilities includes grants for feasibility studies or patent deposits.


\ TRADE & INVESTMENT OFFICES

ATLANTA Djazia FILOSO (Wallonia) [email protected] Wim VAN CAUTEREN (Brussels & Flanders) [email protected]

BOSTON Maxime VAN CAUTER (Wallonia - Technology Attaché) [email protected]

CHICAGO Gilles Philippart de FOY (Wallonia) [email protected] Jean-Pierre VASAUNE (Wallonia - Investment) [email protected] Piet MORISSE (Flanders & Brussels) [email protected] Claude STOMP (Flanders - Investment) [email protected]

HOUSTON Yves DUBUS (Brussels & Wallonia) [email protected]

LOS ANGELES & SAN FRANCISCO Baudouin de HEMPTINNE (Wallonia) [email protected] Eric GABRYS (Brussels) [email protected] Tonia VAN de VYVER (Flanders) [email protected]

NEW YORK Luc LIPPENS (Brussels) [email protected] Edith MAYEUX (Wallonia) [email protected] Benoit REINARDS (Flanders - Investment) [email protected] Luc STRYBOL (Flanders) [email protected] Jan WAUTERS (Flanders - Technology Attaché) [email protected]

WASHINGTON Bernard GEENEN (Brussels & Wallonia) [email protected]

Meet Belgian and Flemish companies at BIO 2016, San Francisco

Health & Medicine

Transcript of Meet Belgian and Flemish companies at BIO 2016, San Francisco